Helixmith Co., Ltd (KOSDAQ:084990)
6,060.00
-70.00 (-1.14%)
Oct 10, 2025, 3:30 PM KST
Helixmith Revenue
Helixmith had revenue of 612.74M KRW in the quarter ending June 30, 2025, a decrease of -14.95%. This brings the company's revenue in the last twelve months to 4.98B, up 57.12% year-over-year. In the year 2024, Helixmith had annual revenue of 4.97B with 18.38% growth.
Revenue (ttm)
4.98B
Revenue Growth
+57.12%
P/S Ratio
56.04
Revenue / Employee
85.85M
Employees
58
Market Cap
279.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.97B | 772.35M | 18.38% |
Dec 31, 2023 | 4.20B | 1.40B | 50.08% |
Dec 31, 2022 | 2.80B | 483.36M | 20.87% |
Dec 31, 2021 | 2.32B | -1.93B | -45.48% |
Dec 31, 2020 | 4.25B | -206.22M | -4.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |
Helixmith News
- 6 months ago - P/E Ratio Insights for Vipshop Holdings - Benzinga
- 1 year ago - Price Over Earnings Overview: Vipshop Holdings - Benzinga